TITLE

Medos acquires Gish to create U.S. production base

AUTHOR(S)
McNulty, Mike
PUB. DATE
July 2007
SOURCE
Rubber & Plastics News;7/23/2007, Vol. 36 Issue 26, p4
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the company Medos Medizintechnik A .G. with emphasis on its purchase of Gish Biomedical Inc. The author argues that the purchase worth $7.5 million was part of he plan of Medos Medizintechnik to establish itself as on of the major players in the US medical market. Gish Biomedical Inc. manufactures a wide array of medical products.
ACCESSION #
25940873

 

Related Articles

  • Acquisitions.  // Biomedical Business & Technology;Aug2007, Vol. 30 Issue 8, p22 

    The article offers news briefs on acquisitions in the biomedical technology industry. An acquisition offer of $4.3 billion has been given by Advanced Medical Optics to larger eye care company Bausch & Lomb. ATS Medical has completed its acquisition of surgical cryoablation company CryoCath...

  • New products information.  // Perfusion;1999, Vol. 14 Issue 2, p157 

    Provides information on two medical devices released in the United States. HILITE 7000 membrane oxygenator from Medos Medizintechnik GmbH; Vacuum-assisted venous drainage from Terumo Medical Corporation.

  • Marketing and mergers. Tosh, Mark // Medical Marketing & Media;Nov2003, Vol. 38 Issue 11, p8 

    Comments on the trend for the consolidation of medical marketing companies in the U.S. Effect of the pressure to produce earnings growth; Decrease of marketing opportunities; Impact of low asset values.

  • After major acquisitions, Getinge/Castle bigger than ever in the OR. Berklan, James M. // Healthcare Purchasing News;May2001, Vol. 25 Issue 5, p23 

    Focuses on the acquisitions made by surgical equipment manufacturer Getinge/Castle in 2001. Aim in acquiring the companies; Market share of Getinge/Castle; Competition faced by the company.

  • First serial in vivo results of mechanical circulatory support in children with a new diagonal pump. Fleck, Thilo; Benk, Christoph; Klemm, Rolf; Kroll, Johannes; Siepe, Matthias; Grohmann, Jochen; Höhn, René; Humburger, Frank; Beyersdorf, Friedhelm; Stiller, Brigitte // European Journal of Cardio-Thoracic Surgery;Nov2013, Vol. 44 Issue 5, p828 

    OBJECTIVES Mechanical circulatory support (MCS) is a rescue therapy for infants and children suffering from severe cardiorespiratory failure with specific system-related complications like bleeding, thromboembolism and device failure. Novel circuit components for temporary MCS with improved...

  • CardioTech completes Gish sale; Haemonetics acquires Infonale.  // Medical Device Daily;7/11/2007, Vol. 11 Issue 132, p2 

    This section offers news briefs on the medical equipment industry in the U.S. The sale of Gish Biomedical by CardioTech International to Medos Medizintechnik has been completed. Software developer Infonale has been acquired by Haemonetics, a global developer of blood management solutions....

  • Hi-Tech pumps up though acquisitions. Dawson, Brad // Rubber & Plastics News;7/23/2007, Vol. 36 Issue 26, p1 

    The article discusses the acquisition by the medical components supplier Hi-Tech Group of three manufacturing operations. According to the author, Hi-Tech Group will acquire Accusil Inc. which was founded by Bill Depel and Jim Mondschean. Accusil Inc. molds silicone parts for medical device...

  • Following TL, Grifols Aims for Big U.S. Bond Splash. Sheahan, Matthew // High Yield Report;10/18/2010, Vol. 21 Issue 42, p17 

    The article reports on the plan of Spanish pharmaceutical and medical supply company Grifols to bring a 1.1 billion U.S. dollars junk bond deal to the U.S. market. Grifols, a supplier of blood plasma products to hospitals, plans to use the debt to finance its acquisition of U.S.-based...

  • Cheers for Thermo deal. Mantone, Joseph // Modern Healthcare;5/15/2006, Vol. 36 Issue 20, p12 

    The article reports on the acquisition of laboratory supply vendor Fisher Scientific International by Thermo Electron Corp. The deal is a stock transaction and is expected to close in the fourth quarter of 2006. About 20% of the combined company's expected 2007 revenue will be generated by...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics